Frailty Assessment and Intervention in Elderly Patients with Gastric Cancer Receiving Gastrectomy and Adjuvant Chemotherapy
NCT06055387 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2025-02-13
Summary
Gastric cancer ranks among the top ten leading causes of death in Taiwan. Radical surgery is the sole curative method for gastric cancer. However, our previous research has revealed that elderly gastric cancer patients undergoing radical surgery face a significantly elevated risk of postoperative complications. Even after gastric cancer resection, only 70% of patients receive adjuvant chemotherapy, with a particularly low likelihood among those aged ≥ 65 to undergo such treatment. With the increasing elderly population in our country, an increasing number of elderly gastric cancer patients must decide whether they can withstand radical surgery for gastric cancer and whether to undergo adjuvant chemotherapy. Therefore, increasing the rates of elderly gastric cancer patients undergoing radical surgery and adjuvant chemotherapy, as well as improving the success rate of chemotherapy, has become a critical issue.
Frailty has been a frequent topic in geriatric medicine in recent years. It involves assessing multifaceted aspects of physical functioning to determine an individual's frailty status, which can help predict the likelihood of severe side effects from medical interventions. International organizations like the American Cancer Society recommend frailty assessment for all elderly cancer patients before undergoing chemotherapy and corresponding interventions to address frailty. However, there is a lack of large-scale studies on frailty assessment and its practical clinical benefits in our population.
This study is a prospective, open-label, randomized clinical trial designed to investigate the impact of geriatric intervention on the tolerance of surgery/chemotherapy in patients diagnosed with gastric cancer. As part of the study protocol, all enrolled patients will undergo a comprehensive frailty assessment within a window of 7 days before initiating their first treatment, followed by tailored geriatric interventions.
The primary objective of this study is to assess and compare the effects of geriatric intervention on postoperative complications, chemotherapy tolerance, treatment-related toxicity, and overall quality of life among two distinct groups: frail and non-frail patients. Our research team aims to promote widespread frailty assessment and interventions with the following objectives:
1. Reduce the probability of postoperative complications among elderly gastric cancer patients receiving surgery.
2. Enhance the tolerance and success rate of adjuvant chemotherapy for gastric cancer.
These efforts ultimately aim to improve the survival prognosis of this patient group.
Conditions
Interventions
- BEHAVIORAL
-
Frailty intervention measures
Providing specialized guidance: * Physical Function and Fall History: * Prioritizing home safety for those with physical impairments. * Arranging rehab consultations when necessary. * Nutrition: * Assessing diets and offering education. * Pre-treatment nutritionist assessments. * Monitoring weight, intervening if \>5-10% loss, or \>10% loss. * Social Support: * Evaluating the needs of those without family support. * Referring to social services and introducing care resources. * Cognition: * Detecting cognitive issues, addressing reversible causes. * Assessing decision-making and medication self-administration. * Refer to specialists when needed. * Polypharmacy and Comorbidity: * Collecting medication data, ensuring adherence. * Noting chronic illnesses. * Collaborating with specialists or pharmacists for complex cases. * Psychological: * Providing weekly support for psychological concerns. * Refer to specialists for assessments and treatment options.
Sponsors & Collaborators
-
Ministry of Health and Welfare, Taiwan
collaborator OTHER_GOV -
Chang Gung Memorial Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
A Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric Cancer
NCT06042998 ·Status: RECRUITING ·Phase: NA
-
Sarcopenia and Multimodal Rehabilitation on the Prognosis of Rectal Cancer Patients Receiving CCRT
NCT05664607 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer
NCT02955173 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer
NCT05892289 ·Status: RECRUITING ·Phase: NA
-
Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients
NCT03564834 ·Status: UNKNOWN ·Phase: PHASE2
-
Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors
NCT06566222 ·Status: NOT_YET_RECRUITING
-
Clinical Outcomes of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer
NCT03313700 ·Status: COMPLETED ·Phase: NA
-
Relationship Between Perioperative Treatment Efficacy and The Tumor Microenvironment for Locally Advanced Resectable Gastric Cancer.
NCT04850729 ·Status: RECRUITING
-
the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer
NCT05235932 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Tubeless NOSES Versus Laparoscopic Radical Resection for Rectosigmoid Cancers
NCT04037956 ·Status: RECRUITING ·Phase: NA
-
Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal Gastrectomy
NCT03613142 ·Status: UNKNOWN ·Phase: NA
-
Effect Study of Clinical Outcomes of Traditional Chinese Medicine to Advanced Gastric Cancer by Propensity Score
NCT02781285 ·Status: UNKNOWN
-
Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer
NCT06831669 ·Status: RECRUITING
-
Predicting Gastric Cancer Response to Chemo With Multimodal AI Model
NCT06451393 ·Status: RECRUITING
-
Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction or Upper Gastric Adenocarcinoma
NCT02193594 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Predict 5-Year Survival in Elderly Gastric Cancer
NCT06208046 ·Status: COMPLETED
-
Single-port Robotic Radical Gastrectomy for Gastric Cancer
NCT07237126 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Gastric Cancer Patients
NCT05584592 ·Status: UNKNOWN ·Phase: NA
-
Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China
NCT06717178 ·Status: RECRUITING
-
Feasibility Study of Sentinel Navigation Surgery After Non-curative Endoscopic Resection
NCT03123042 ·Status: COMPLETED ·Phase: NA
-
Assessment of Efficacy of Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT06314737 ·Status: COMPLETED
-
Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer
NCT05496270 ·Status: COMPLETED
-
Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric Cancer
NCT03314649 ·Status: COMPLETED
-
Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon Cancer
NCT06485609 ·Status: RECRUITING ·Phase: NA
-
Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients
NCT01268943 ·Status: COMPLETED ·Phase: PHASE1